v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities:    
Net loss $ (16,611,425) $ (5,705,098)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 446,449 256,895
Stock-based compensation 497,164 614,115
Inventory reserve adjustments   28,012
Amortization of debt discount   789,871
Amortization of deferred financing costs 28,433 236,550
Operating lease right-of-use asset   93,626
Change in fair value of warrant liabilities (127,300) (3,311)
Change in fair value of derivative liability (37,900) 0
Change in fair value of debt (256,522) 0
Loss on issuance of debt 707,800 0
Loss on extinguishment of debt 5,497,516 0
Gain on sale of intellectual property intangible assets (8,961,872) 0
Loss on impairment of inventories, property and equipment and operating lease right-of-use asset 6,064,823  
Interest expense recognized on remeasurement of preferred stock liability 10,398,050  
Changes in operating assets and liabilities:    
Accounts receivable   349,657
Inventories   (218,542)
Prepaid expenses and other current assets (42,171) 97,295
Accounts payable (94,398) 952,936
Accrued expenses 681,210 524,487
Contract liabilities   (23,400)
Operating lease liability (117,649) (86,535)
Net cash used in operating activities (1,927,792) (2,093,442)
Cash Flows from Investing Activities:    
Purchase of property and equipment (600,000)  
Payments under convertible note receivable (150,000)  
Net cash used in investing activities (750,000)  
Cash Flows from Financing Activities:    
Proceeds from debt borrowings 2,394,708  
Repayments of debt (835,316)  
Payments of debt issuance costs and discounts (20,000)  
Proceeds received from settlement 1,000,000  
Proceeds from issuance of common stock   200,000
Restricted stock units used for tax withholdings   (1,873)
Payment of deferred financing costs   (21,500)
Net cash provided by financing activities 2,539,392 176,627
NET CHANGE IN CASH DURING THE PERIOD (138,400) (1,916,815)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 209,337 2,148,700
CASH AND CASH EQUIVALENTS - END OF PERIOD 70,937 231,885
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of Common Stock upon extinguishment of debt 4,390,251  
Issuance of Common Stock upon exercise of pre-funded warrants 934  
Deemed dividend in connection with modification of pre-funded warrants 936  
Shareholder advance to promissory note 545,000  
Conversion of debt to common stock 306,459  
Initial fair value of convertible note receivable over proceeds paid $ 110,000  
Transfer of property and equipment from inventory   68,499
Purchase of property and equipment in accounts payable and accrued expenses   540,028
Deferred financing costs included in accounts payable and accrued expenses   697,563
Transaction costs related to the reverse recapitalization not yet paid   $ 1,007,439